Skip to main content
. 2020 Jun 16;29:100556. doi: 10.1016/j.ijcha.2020.100556

Table 4.

Relationship of heart rhythm on ECG with symptom status and health perception.

AF Rhythm (n = 1610, 41.0%)
AFL Rhythm (n = 80, 2.0%)
Adjustment OR (95% CI) p-value OR (95% CI) p-value
Any symptom Age and sex 0.56 (0.49–0.66) <0.0001 2.11 (1.16–3.84) 0.01
Multivariate* 0.60 (0.51–0.70) <0.0001 2.30 (1.26–4.20) 0.007
Palpitations Age and sex 0.50 (0.43–0.57) <0.0001 1.88 (1.17–3.03) 0.009
Multivariate* 0.55 (0.47–0.64) <0.0001 2.09 (1.30–3.39) 0.003
Dyspnea Age and sex 1.14 (0.97–1.33) 0.12 3.40 (2.16–5.35) <0.0001
Multivariate* 1.05 (0.90–1.25) 0.53 3.38 (2.13–5.35) <0.0001
Chest pain Age and sex 0.77 (0.62–0.96) 0.02 1.92 (1.09–3.38) 0.02
Multivariate* 0.75 (0.60–0.95) 0.02 1.95 (1.10–3.46) 0.02
Effort intolerance Age and sex 0.71 (0.59–0.85) 0.0002 1.23 (0.72–2.08) 0.45
Multivariate* 0.71 (0.59–0.85) 0.0003 1.29 (0.76–2.20) 0.36
Fatigue Age and sex 1.03 (0.86–1.24) 0.73 1.55 (0.91–2.65) 0.11
Multivariate* 1.02 (0.84–1.22) 0.86 1.60 (0.93–2.74) 0.09
Dizziness Age and sex 0.66 (0.54–0.80) <0.0001 0.73 (0.37–1.43) 0.36
Multivariate* 0.65 (0.53–0.80) <0.0001 0.72 (0.37–1.43) 0.35
Syncope Age and sex 0.41 (0.26–0.65) 0.0001 0.64 (0.16–2.66) 0.54
Multivariate* 0.43 (0.27–0.69) 0.0004 0.64 (0.15–2.67) 0.54
Anxiety Age and sex 0.46 (0.32–0.67) <0.0001 0.23 (0.03–1.65) 0.14
Multivariate* 0.50 (0.34–0.73) 0.0004 0.26 (0.04–1.91) 0.19



β-coefficient (95% CI) p-value β-coefficient (95% CI) p-value

Health perception
VAS 0-100
Age and sex −5.37 (−6.57 to −4.17) <0.0001 −11.66 (−15.61 to 7.71) <0.0001
Multivariate* −3.69 (−4.89 to 2.49) <0.0001 −9.70 (−13.56 to −5.84) <0.0001

ORs (95% CIs) and β –coefficient (95% CIs) are for patients in AF-, respectively AFL-rhythm, compared with patients in Sinus rhythm.

AF indicates atrial fibrillation; AFL, atrial flutter; CI, confidence interval; OR, odds ratio; VAS, Visual Analog Scale.

n = 3684.

*

Multivariable models were adjusted for age, sex, body mass index, hypertension, heart failure, diabetes mellitus, coronary heart disease (myocardial infarction, percutaneous transluminal coronary angioplasty, or aortocoronary bypass) and antiarrhythmic drugs.